title: Telaprevir and boceprevir: a potential role for therapeutic drug monitoring.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Dolton
authors.forename: John E
authors.initials: JE
authors.lastname: Ray
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: McLachlan
mesh_terms: D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D016903:Drug Monitoring / Q000379:methods*; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D009842:Oligopeptides / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011392:Proline / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline